Immvention Therapeutix is partnering with Novo Nordisk to develop oral treatments for sickle cell disease (SCD) and other ...

Stem cell transplant in young adults and adolescents with severe sickle cell disease may be a feasible option, according to a ...

FRIDAY, Jan. 24, 2025 (HealthDay News) -- People with sickle cell disease often struggle with memory, focus, learning and problem solving, setting them back in school and the workplace. That could be ...

DURHAM, NC, USA I2, 2025 I IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human ...

Today Early in the fall, experts might also see more cases of respiratory syncytial virus, Dr. Geeta Sood, assistant professor of medicine and epidemiologist at Johns Hopkins Bayview Medical Center, ...

Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical studies. The drug is mutation-agnostic, a ...

Under Emirates Health Services (EHS) theme "Future Health Now", EHS is participating in the 50th edition of Arab Health 2025, ...

28, 2025 — A team of stem cell scientists have successfully used ... DNA Damage Can Last Unrepaired for Years, Changing Our View of Mutations Jan. 15, 2025 — While most known types of DNA ...

Recent studies have demonstrated the utility of the Pig-A mutation assay in various contexts. For instance, a study involving pediatric patients with sickle cell disease treated with hydroxyurea ...

Genetic Carriers for Sickle Cell Disease Have Higher Risks of Blood ... in women who have any combination of a particular gene mutation, estrogen use, or common medical conditions -- specifically ...

Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical ...